[1]JournalofMedicinalChemistry,2007,vol.50,p.5752-5764
[2]EuropeanJournalofMedicinalChemistry,2012,vol.52,p.1-13
[3]Patent:US2513826,1946,
1138-54-1
98-68-0
98995-40-5
1132-17-8
204072-53-7
58076-32-7
154365-37-4 | Ethyl 2-methyl-6-nitro-3-oxo-3,4-dihydro-2h-1,4-benzoxazine-2-carboxylate | AA00AZKG | MFCD08443979
16353-07-4 | 6-Propylpyrimidin-4(1H)-one | AA00B2PM | MFCD12032876
15460-12-5 | 2,4-Dibromo-6-tert-butylphenol | AA00B4TI | MFCD00463268
149489-21-4 | 2-(2-Fluoropyridin-3-yl)ethanol | AA00B86Q | MFCD09926577
187217-99-8 | 1-(2,2,2-Trifluoroethyl)piperidin-4-amine | AA00BARY | MFCD09040660
27041-17-4 | 2-Bromoheptafluoronaphthalene | AA00BBI4 | MFCD07784218
26638-43-7 | Methyl 2-(chlorosulfonyl)benzoate | AA00BBP2 | MFCD00009797
270596-53-7 | (S)-3-Amino-4-(4-fluorophenyl)butanoic acid, HCl | AA00BBY2 | MFCD01861012
2385-85-5 | MIREX | AA00BC5W | MFCD00167995
215190-23-1 | Fmoc-d-styrylalanine | AA00BCFX | MFCD01311775